Abstract
In recent years, the publication of the studies on the transmissibility in mammals of the H5N1 influenza virus and synthetic genomes has triggered heated and concerned debate within the community of scientists on biological dual-use research; these papers have raised the awareness that, in some cases, fundamental research could be directed to harmful experiments, with the purpose of developing a weapon that could be used by a bioterrorist. Here is presented an overview regarding the dual-use concept and its related international agreements which underlines the work of the Australia Group (AG) Export Control Regime. It is hoped that the principles and activities of the AG, that focuses on export control of chemical and biological dual-use materials, will spread and become well known to academic researchers in different countries, as they exchange biological materials (i.e. plasmids, strains, antibodies, nucleic acids) and scientific papers. To this extent, and with the aim of drawing the attention of the scientific community that works with yeast to the so called Dual-Use Research of Concern, this article reports case studies on biological dual-use research and discusses a synthetic biology applied to the yeast Saccharomyces cerevisiae, namely the construction of the first eukaryotic synthetic chromosome of yeast and the use of yeast cells as a factory to produce opiates. Since this organism is considered harmless and is not included in any list of biological agents, yeast researchers should take simple actions in the future to avoid the sharing of strains and advanced technology with suspicious individuals.
Similar content being viewed by others
References
Annaluru, N., Muller, H., Mitchell, L. A., Ramalingam, S., Stracquadanio, G., Richardson, S. M., et al. (2014). Total synthesis of a functional designer eukaryotic chromosome. Science, 344(6179), 55–58.
Atlas, R., Campbell, P., Cozzarelli, N. R., Curfman, G., Enquist, L., Fink, G., et al. (2003). Statement on the consideration of biodefense and biosecurity. Nature, 421(6925), 771.
Barash, J. R., & Arnon, S. S. (2014). A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. Journal of Infectious Diseases, 209(2), 183–191.
Beaudoin, G. A. W. (2015). Characterization of oxidative enzymes involved in the biosynthesis of benzylisoquinoline alkaloids in opium poppy (Papaver somniferum). Ph.D thesis, University of Calgary. Available at http://hdl.handle.net/11023/2115
Berns, K. I., Casadevall, A., Cohen, M. L., Ehrlich, S. A., Enquist, L. W., Fitch, J. P., et al. (2012). Adaptations of avian flu virus are a cause for concern. Science, 335(6069), 660–661.
Bügl, H., Danner, J. P., Molinari, R. J., Mulligan, J. T., Park, H. O., Reichert, B., et al. (2007). DNA synthesis and biological security. Nature Biotechnology, 25(6), 627–629.
Cameron, D. E., Bashor, C. J., & Collins, J. J. (2014). A brief history of synthetic biology. Nature Reviews Microbiology, 12(5), 381–390.
Charatsis, C. (2015). Setting the publication of ‘dual-use research’ under the export authorisation process: The H5N1 case. Strategic Trade Review, 1, 56–72.
Collett, M. S. (2006). Impact of synthetic genomics on the threat of bioterrorism with viral agents. In Garfinkel, M.S., Endy, D., Epstein, G.L., Friedman, R.M. (Eds.), Working papers for synthetic genomics: Risks and benefits for science and society, pp. 83–103.
DeLoache, W. C., Russ, Z. N., Narcross, L., Gonzales, A. M., Martin, V. J., & Dueber, J. E. (2015). An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose. Nature Chemical Biology, 11, 465–471.
Dover, N., Barash, J. R., Hill, K. K., Xie, G., & Arnon, S. S. (2014). Molecular characterization of a novel botulinum neurotoxin type H gene. Journal of Infectious Diseases, 209(2), 192–202.
Dymond, J. S., Richardson, S. M., Coombes, C. E., Babatz, T., Muller, H., Annaluru, N., et al. (2011). Synthetic chromosome arms function in yeast and generate phenotypic diversity by design. Nature, 477(7365), 471–476.
Edwards, B., Revill, J., & Bezuidenhout, L. (2014). From cases to capacity? A critical reflection on the role of ‘ethical dilemmas’ in the development of dual-use governance. Science and Engineering Ethics, 20(2), 571–582.
Enia, J., & Fields, J. (2014). The relative efficacy of the biological and chemical weapon regimes. The Nonproliferation Review, 21(1), 43–64.
Enserink, M. (2012). Will dutch allow ‘export’ of controversial flu study? Science, 336(6079), 285.
Enserink, M. (2013). Dutch H5N1 ruling raises new questions. Science, 342(6155), 178.
Enserink, M. (2015). As new botulism threat implodes, more questions. Science, 347(6225), 934–935.
Evans, S. A., & Valdivia, W. D. (2012). Export controls and the tensions between academic freedom and national security. Minerva, 50(2), 169–190.
Fossati, E., Narcross, L., Ekins, A., Falgueyret, J. P., & Martin, V. J. (2015). Synthesis of morphinan alkaloids in Saccharomyces cerevisiae. PLoS ONE, 10(4), e0124459.
Galanie, S., Thodey, K., Trenchard, I. J., Interrante, M. F., & Smolke, C. D. (2015). Complete biosynthesis of opioids in yeast. Science, 349, 1095–1100.
Gibson, D. G., Glass, J. I., Lartigue, C., Noskov, V. N., Chuang, R. Y., Algire, M. A., et al. (2010). Creation of a bacterial cell controlled by a chemically synthesized genome. Science, 329(5987), 52–56.
Gibson, D. G., & Venter, J. C. (2014). Synthetic biology: Construction of a yeast chromosome. Nature, 509(7499), 168–169.
Gronvall, G. K. (2013). H5N1: A case study for dual-use research. New York, NY: Council on Foreign Relations.
Gurkan, C., & Ellar, D. J. (2005). Recombinant production of bacterial toxins and their derivatives in the methylotrophic yeast Pichia pastoris. Microbial Cell Factories, 4(1), 1.
Herfst, S., Schrauwen, E. J., Linster, M., Chutinimitkul, S., de Wit, E., Munster, V. J., et al. (2012). Airborne transmission of influenza A/H5N1 virus between ferrets. Science, 336(6088), 1534–1541.
Herrlich, P. (2013). The responsibility of the scientist. EMBO Reports, 14(9), 759–764.
Hooper, D. C., & Hirsch, M. S. (2014). Novel Clostridium botulinum toxin and dual use research of concern issues. Journal of Infectious Diseases, 209(2), 167.
Hunter, P. (2012). H5N1 infects the biosecurity debate. EMBO Reports, 13(7), 604–607.
Imai, M., Watanabe, T., Hatta, M., Das, S. C., Ozawa, M., Shinya, K., et al. (2012). Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature, 486(7403), 420–428.
Jackson, R. J., Ramsay, A. J., Christensen, C. D., Beaton, S., Hall, D. F., & Ramshaw, I. A. (2001). Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. Journal of Virology, 75(3), 1205–1210.
Kalb, S. R., Baudys, J., Raphael, B. H., Dykes, J. K., Luquez, C., Maslanka, S. E., & Barr, J. R. (2015). Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A). Analytical Chemistry, 87(7), 3911–3917.
Kelle, A. (2009). Synthetic biology and biosecurity. EMBO Reports, 10(1S), S23–S27.
Kelle, A. (2013). Beyond patchwork precaution in the dual-use governance of synthetic biology. Science and Engineering Ethics, 19(3), 1121–1139.
Kelle, A. (2014). Prohibiting chemical and biological weapons: Multilateral regimes and their evolution. Incorporated: Lynne Rienner Publishers.
Kuhlau, F., Eriksson, S., Evers, K., & Höglund, A. T. (2008). Taking due care: Moral obligations in dual use research. Bioethics, 22(9), 477–487.
Kumar Singh, M., Kumar Dhaked, R., Singh, P., Gupta, P., & Singh, L. (2011). Characterization of LC-HCC fusion protein of botulinum neurotoxin type A. Protein and Peptide Letters, 18(3), 295–304.
Lartigue, C., Vashee, S., Algire, M. A., Chuang, R. Y., Benders, G. A., Ma, L., et al. (2009). Creating bacterial strains from genomes that have been cloned and engineered in yeast. Science, 325(5948), 1693–1696.
Liu, B., Shi, D., Chang, S., Gong, X., Yu, Y., Sun, Z., & Wu, J. (2015). Characterization and immunological activity of different forms of recombinant secreted Hc of botulinum neurotoxin serotype B products expressed in yeast. Scientific Reports, 5, 7678. doi:10.1038/srep07678.
Miller, S., & Selgelid, M. J. (2007). Ethical and philosophical consideration of the dual-use dilemma in the biological sciences. Science and Engineering Ethics, 13(4), 523–580.
National Research Council (2004). Biotechnology research in an age of terrorism. Committee on research standards and practices to prevent the destructive application of biotechnology. Washington, D.C.: National Academies Press.
Oye, K. A., Lawson, J. C., & Bubela, T. (2015). Drugs: Regulate ‘home-brew’ opiates. Nature, 521(7552), 281.
Paddon, C. J., Westfall, P. J., Pitera, D. J., Benjamin, K., Fisher, K., McPhee, D., et al. (2013). High-level semi-synthetic production of the potent antimalarial artemisinin. Nature, 496(7446), 528–532.
Rath, J., Ischi, M., & Perkins, D. (2014). Evolution of different dual-use concepts in international and national law and its implications on research ethics and governance. Science and Engineering Ethics, 20(3), 769–790.
Relman, D. A. (2013). The increasingly compelling moral responsibilities of life scientists. Hastings Center Report, 43(2), 34–35.
Suk, J. E., Zmorzynska, A., Hunger, I., Biederbick, W., Sasse, J., Maidhof, H., & Semenza, J. C. (2011). Dual-use research and technological diffusion: Reconsidering the bioterrorism threat spectrum. PLoS Pathogens, 7(1), e1001253.
Thodey, K., Galanie, S., & Smolke, C. D. (2014). A microbial biomanufacturing platform for natural and semisynthetic opioids. Nature Chemical Biology, 10, 837–844.
Tucker, J. B. (Ed.). (2012). Innovation, dual use, and security: Managing the risks of emerging biological and chemical technologies. Cambridge, MA: MIT Press.
Uhlenhaut, C., Burger, R., & Schaade, L. (2013). Protecting society. EMBO Reports, 14(1), 25–30.
van der Bruggen, K. (2012). Possibilities, intentions and threats: Dual use in the life sciences reconsidered. Science and Engineering Ethics, 18(4), 741–756.
Webster, R. G. (2012). Mammalian-transmissible H5N1 influenza: The dilemma of dual-use research. MBio, 3(1), e00005-12.13.
Yong, E. (2012). Mutant-flu paper published. Nature, 485, 13–14.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cirigliano, A., Cenciarelli, O., Malizia, A. et al. Biological Dual-Use Research and Synthetic Biology of Yeast. Sci Eng Ethics 23, 365–374 (2017). https://doi.org/10.1007/s11948-016-9774-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11948-016-9774-1